FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2730159658> ?p ?o ?g. }

• W2730159658 endingPage "3731" @default.
• W2730159658 startingPage "3725" @default.
• W2730159658 abstract "Regorafenib, a multikinase inhibitor, has demonstrated prolonged survival by 2.8 months as a second-line agent in patients with hepatocellular carcinoma (HCC) who progress on sorafenib therapy. The objective of the current study was to examine the cost effectiveness of regorafenib for the treatment of HCC.The authors constructed a Markov simulation model of patients with unresectable HCC and Child-Pugh A cirrhosis who received treatment with regorafenib versus best supportive care. Model inputs for regorafenib effectiveness and rates of adverse events in patients with HCC were based on published clinical trial data and literature review. Quality-adjusted life years (QALYs) were calculated along with the incremental cost-effectiveness ratio (ICER) of regorafenib therapy. One-way sensitivity analyses also were conducted simultaneously on all model parameters and on various Monte-Carlo simulation parameters, and the regorafenib cost threshold at which cost effectiveness would be achieved was determined.Regorafenib provided an increase of 0.18 QALYs at a cost of $47,112. The ICER for regorafenib, compared with best supportive care, was $224,362. In 1-way sensitivity analyses, there were no scenarios in which regorafenib was cost effective. In cost threshold analysis, regorafenib would have to be priced at or below $67 per pill to be cost effective at an ICER of $100,000.Regorafenib is not cost effective as a second-line agent in the treatment of HCC, with a marginal increase in QALYs at a high cost. Lowering the cost of regorafenib or improving the selection of patients who can achieve maximal survival benefit would improve its value as a second-line treatment option for patients with HCC. Cancer 2017;123:3725-3731. © 2017 American Cancer Society." @default.
• W2730159658 created "2017-07-14" @default.
• W2730159658 creator A5014214683 @default.
• W2730159658 creator A5035376582 @default.
• W2730159658 creator A5040663276 @default.
• W2730159658 date "2017-06-29" @default.
• W2730159658 modified "2023-10-13" @default.
• W2730159658 title "Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma" @default.
• W2730159658 cites W1828082159 @default.
• W2730159658 cites W1929386821 @default.
• W2730159658 cites W1968812902 @default.
• W2730159658 cites W1971837077 @default.
• W2730159658 cites W1995517770 @default.
• W2730159658 cites W2020677481 @default.
• W2730159658 cites W2033156884 @default.
• W2730159658 cites W2037286749 @default.
• W2730159658 cites W2043951092 @default.
• W2730159658 cites W2045336712 @default.
• W2730159658 cites W2051684210 @default.
• W2730159658 cites W2058056848 @default.
• W2730159658 cites W2102942095 @default.
• W2730159658 cites W2113720307 @default.
• W2730159658 cites W2116922255 @default.
• W2730159658 cites W2119942470 @default.
• W2730159658 cites W2127448855 @default.
• W2730159658 cites W2128965737 @default.
• W2730159658 cites W2139504369 @default.
• W2730159658 cites W2147834058 @default.
• W2730159658 cites W2163403599 @default.
• W2730159658 cites W2282228285 @default.
• W2730159658 cites W2294765885 @default.
• W2730159658 cites W2403816580 @default.
• W2730159658 cites W2502891277 @default.
• W2730159658 cites W2538027703 @default.
• W2730159658 cites W2552432336 @default.
• W2730159658 cites W2560499218 @default.
• W2730159658 cites W2586399611 @default.
• W2730159658 cites W2603749172 @default.
• W2730159658 doi "https://doi.org/10.1002/cncr.30863" @default.
• W2730159658 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28662266" @default.
• W2730159658 hasPublicationYear "2017" @default.
• W2730159658 type Work @default.
• W2730159658 sameAs 2730159658 @default.
• W2730159658 citedByCount "62" @default.
• W2730159658 countsByYear W27301596582017 @default.
• W2730159658 countsByYear W27301596582018 @default.
• W2730159658 countsByYear W27301596582019 @default.
• W2730159658 countsByYear W27301596582020 @default.
• W2730159658 countsByYear W27301596582021 @default.
• W2730159658 countsByYear W27301596582022 @default.
• W2730159658 countsByYear W27301596582023 @default.
• W2730159658 crossrefType "journal-article" @default.
• W2730159658 hasAuthorship W2730159658A5014214683 @default.
• W2730159658 hasAuthorship W2730159658A5035376582 @default.
• W2730159658 hasAuthorship W2730159658A5040663276 @default.
• W2730159658 hasBestOaLocation W27301596581 @default.
• W2730159658 hasConcept C112930515 @default.
• W2730159658 hasConcept C121608353 @default.
• W2730159658 hasConcept C126322002 @default.
• W2730159658 hasConcept C143998085 @default.
• W2730159658 hasConcept C197934379 @default.
• W2730159658 hasConcept C2776248978 @default.
• W2730159658 hasConcept C2778019345 @default.
• W2730159658 hasConcept C2778695046 @default.
• W2730159658 hasConcept C3019080777 @default.
• W2730159658 hasConcept C526805850 @default.
• W2730159658 hasConcept C71924100 @default.
• W2730159658 hasConceptScore W2730159658C112930515 @default.
• W2730159658 hasConceptScore W2730159658C121608353 @default.
• W2730159658 hasConceptScore W2730159658C126322002 @default.
• W2730159658 hasConceptScore W2730159658C143998085 @default.
• W2730159658 hasConceptScore W2730159658C197934379 @default.
• W2730159658 hasConceptScore W2730159658C2776248978 @default.
• W2730159658 hasConceptScore W2730159658C2778019345 @default.
• W2730159658 hasConceptScore W2730159658C2778695046 @default.
• W2730159658 hasConceptScore W2730159658C3019080777 @default.
• W2730159658 hasConceptScore W2730159658C526805850 @default.
• W2730159658 hasConceptScore W2730159658C71924100 @default.
• W2730159658 hasIssue "19" @default.
• W2730159658 hasLocation W27301596581 @default.
• W2730159658 hasLocation W27301596582 @default.
• W2730159658 hasLocation W27301596583 @default.
• W2730159658 hasOpenAccess W2730159658 @default.
• W2730159658 hasPrimaryLocation W27301596581 @default.
• W2730159658 hasRelatedWork W2001059786 @default.
• W2730159658 hasRelatedWork W2622529806 @default.
• W2730159658 hasRelatedWork W2755303271 @default.
• W2730159658 hasRelatedWork W2799933121 @default.
• W2730159658 hasRelatedWork W2904776407 @default.
• W2730159658 hasRelatedWork W2922810281 @default.
• W2730159658 hasRelatedWork W2938267598 @default.
• W2730159658 hasRelatedWork W2942632018 @default.
• W2730159658 hasRelatedWork W3105390383 @default.
• W2730159658 hasRelatedWork W4386893315 @default.
• W2730159658 hasVolume "123" @default.
• W2730159658 isParatext "false" @default.
• W2730159658 isRetracted "false" @default.
• W2730159658 magId "2730159658" @default.

• next